Glesatinib (hydrochloride), CAS [[2319837-80-2]]
Artikelnummer:
MCE-HY-19642A
| Artikelname: |
Glesatinib (hydrochloride), CAS [[2319837-80-2]] |
| Artikelnummer: |
MCE-HY-19642A |
| Hersteller Artikelnummer: |
HY-19642A |
| Alternativnummer: |
MCE-HY-19642A-5MG,MCE-HY-19642A-100MG,MCE-HY-19642A-10MG,MCE-HY-19642A-50MG,MCE-HY-19642A-25MG,MCE-HY-19642A-10MMX1ML |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
MGCD265 (hydrochloride) |
| Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. Glesatinib hydrochloride, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC)[1][2]. |
| Molekulargewicht: |
656.17 |
| Reinheit: |
98.01 |
| CAS Nummer: |
[2319837-80-2] |
| Formel: |
C31H28ClF2N5O3S2 |
| Target-Kategorie: |
c-Met/HGFR,TAM Receptor |
| Anwendungsbeschreibung: |
Reference compound |
